Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 12,889,000 | 11,355,000 | 10,983,000 | 10,463,000 | 14,487,000 |
Marketable Securities | 9,392,000 | 22,724,000 | 21,585,000 | 19,925,000 | 17,121,000 |
Receivables | 14,039,000 | 15,890,000 | 16,139,000 | 15,594,000 | 15,283,000 |
Inventories | 10,268,000 | 11,675,000 | 11,437,000 | 10,990,000 | 10,387,000 |
Other current assets | 5,830,000 | 0 | 0 | 0 | 0 |
TOTAL | $55,294,000 | $65,236,000 | $63,847,000 | $60,424,000 | $60,979,000 |
Non-Current Assets | |||||
PPE Net | 17,982,000 | 18,152,000 | 18,354,000 | 18,701,000 | 18,962,000 |
Intangibles | 74,536,000 | 73,719,000 | 76,574,000 | 79,355,000 | 81,638,000 |
Other Non-Current Assets | 39,566,000 | 18,017,000 | 18,949,000 | 19,875,000 | 20,439,000 |
TOTAL | $132,084,000 | $109,888,000 | $113,877,000 | $117,931,000 | $121,039,000 |
Total Assets | $187,378,000 | $175,124,000 | $177,724,000 | $178,355,000 | $182,018,000 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 9,889,000 | 10,153,000 | 9,765,000 | 9,309,000 | 11,055,000 |
Accrued Expenses | 27,347,000 | 28,980,000 | 28,771,000 | 28,076,000 | 29,293,000 |
TOTAL | $55,802,000 | $45,543,000 | $44,821,000 | $43,390,000 | $45,226,000 |
Non-Current Liabilities | |||||
Long Term Debt | 26,886,000 | 27,603,000 | 28,292,000 | 28,851,000 | 29,985,000 |
Other Non-Current Liabilities | 23,895,000 | 22,433,000 | 23,239,000 | 24,981,000 | 25,297,000 |
TOTAL | $54,772,000 | $54,982,000 | $56,546,000 | $60,256,000 | $62,769,000 |
Total Liabilities | $110,574,000 | $100,525,000 | $101,367,000 | $103,646,000 | $107,995,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 2,604,286 | 2,614,484 | 2,629,180 | 2,631,402 | 2,629,268 |
Common Shares | 3,120,000 | 3,120,000 | 3,120,000 | 3,120,000 | 3,120,000 |
Retained earnings | 128,345,000 | 127,917,000 | 126,216,000 | 124,380,000 | 123,060,000 |
Other shareholders' equity | -12,967,000 | -15,292,000 | -13,843,000 | -13,757,000 | -13,058,000 |
TOTAL | $76,804,000 | $74,599,000 | $76,357,000 | $74,709,000 | $74,023,000 |
Total Liabilities And Equity | $187,378,000 | $175,124,000 | $177,724,000 | $178,355,000 | $182,018,000 |